Evidence map›Paper›PMID 31656485›Full record

ArticleAfrican health sciences2019

Prevalence of infectious multi-drug resistant bacteria isolated from immunocompromised patients in Tunisia.

Arij Mechergui, Wafa Achour, Sondos Mathlouthi, Assia Ben Hassen

Open access · diamondAbstract read
In one paragraph

Article in African health sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.5field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Antibiotic Resistance toJournal of dentistry (Shiraz, Iran) · 2025
    Article
  2. Article
  3. Multidrug-Resistant Bacteria in Immunocompromised Patients.Pharmaceuticals (Basel, Switzerland) · 2024
    Review
  4. Observational
  5. Global impact of antibacterial resistance in patients with hematologic malignancies and hematopoietic cell transplant recipients.Transplant infectious disease : an official journal of the Transplantation Society · 2023
    Review
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Arij MecherguiThe National Bone Marrow Transplant Center, 1006, Tunis, Tunisia.
Wafa AchourThe National Bone Marrow Transplant Center, 1006, Tunis, Tunisia.
Sondos MathlouthiThe National Bone Marrow Transplant Center, 1006, Tunis, Tunisia.
Assia Ben HassenThe National Bone Marrow Transplant Center, 1006, Tunis, Tunisia.
Tunis University · TN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesA retrospective study was conducted in the Bone Marrow Transplant Center of Tunisia during a period of 10 years (from 2002 to 2011) in order to report the prevalence of infectious multi-drug resistant bacteria.

methodsBacterial identification was carried on the basis of biochemical characteristics and API identification systems. Antibiotic susceptibility was tested by disc diffusion method on Muller-Hinton agar.

resultsDuring the study period, 34.5% of 142

conclusionThese findings may have important clinical implications in prophylaxis and selection of antibiotic treatment. Continuous surveillance is needed, especially for onco-hematological patients.

Indexed as

Drug Resistance, Multiple, BacterialImmunocompromised HostStem Cell TransplantationAnti-Bacterial AgentsEscherichia coliHumansKlebsiella pneumoniaeMicrobial Sensitivity TestsPrevalencePseudomonas aeruginosaRetrospective StudiesStaphylococcus aureusTunisiaAnti-Bacterial Agentsimmunocompromised patientsInfectious multi-drug resistant bacteriaTunisia

Identifiers

PMID31656485
PMCPMC6794499
OpenAlexW2969439338

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.